Sartorius Biostat A plus Bioreactor System R&D Microbial/Cell Culture 2007
Sartorius
Details
-
CategoryBioreactor / Fermenter
-
Dimension16.0in x 8.0in x 19.0in
-
Serial00351
-
Shipping TypeFedEx Ground
-
Manufacturing2007-01-01
-
Voltage / Hertz120V/220V / 50Hz/60Hz
Description
The Sartorius Biostat A plus Bioreactor System, manufactured in 2007, is designed for preliminary or investigational R&D applications and educational use. This compact bioreactor is particularly suited for microbial and cell culture as well as small-scale protein expression tasks. Its critical features include simple and automated aeration control for up to four gases and an integrated chiller, with an operating temperature range up to 40°C. While it exhibits some cosmetic wear, the system is fully functional and successfully passes all function tests, ensuring its viability for laboratory setups. Please note, computer systems are not included.
Key Features
- Simple and automated aeration control for up to 4 gases
- Integrated chiller
- Temperature range up to 40°C
- Ideal for microbial and cell culture
- Compact design for R&D applications
Specifications
- Manufacturer: Sartorius
- Model: Biostat A plus
- Particularly designed for R&D and educational applications
- Suitable for microbial culture, cell culture, and small-scale protein expression
- Integrated chiller for temperature regulation
- Automated aeration control with up to four gases supported
- Functional with minor cosmetic damage, tested and works as intended
- Voltage: 120V/220V, Hertz: 50Hz/60Hz
- Manufacture Date: January 1, 2007
Weight
Imperial: 54.0 Pounds
Metric: 24.49 Kilograms
Shipping Dimensions
Imperial: 19.2 lb x 9.6 lb x 22.8 lb
Metric: 48.77 cm x 24.38 cm x 57.91 cm
Harmonized Code
841989
Harmonized Code Details
841989 - Machines and mechanical appliances having individual functions, not specified or included elsewhere in this chapter. This code is applicable due to the function-specificity of the bioreactor system in laboratory and educational setups.
Comments 0
There are currently no public comments.